Johnson Johnson starts two-dose trial of its COVID-19 vaccine candidate

Johnson & Johnson launched a new large-scale late-stage trial on November 16 to test a two-dose regimen of its experimental COVID-19 vaccine and evaluate potential incremental benefits for the du… [read more]

Leave a Comment